Registration Open: Compounding Quality Center of Excellence Annual Conference

Subscribe FDA | Center for Drug Evaluation and Research | Office of Compliance COMPOUNDING UPDATE Registration is now open for the Compounding Quality Center of Excellence Annual Conference to be held September 6-8, 2022. This year's theme is: The Shared Pursuit of Compounding Excellence.  This free, virtual conference with an emphasis on outsourcing facilities will convene stakeholders from across the compounding industry. Speakers will discuss emerging trends and best practices through presentations, interactive sessions, and roundtable conversations. Registration is open and will close August 31, 2022. The conference agenda is now available.  Learn More Conference attendees will be eligible for continuing education units (CEU). Details will be provided after registration.   Email CompoundingQualityCoE@fda.hhs.gov for event or registration questions.    FDA's human drug compounding program aims to protect patients from unsafe, ineffective and poor quality compounded drugs, while preserving access to lawfully-marketed compounded drugs for patients who have a medical need for them. Human Drug Compounding Including Policy and Oversight Activity Compounding and FDA: Questions and Answers Compounding Quality Center of Excellence On-Demand Training Compounding Risk Alerts Report an Unexpected Problem with a Compounded Product This is an automated message delivery system, replying to this message will not reach the FDA. Contact us at CompoundingQualityCoE@fda.hhs.gov or 1-866-405-5367 or (301) 796-6707.

Stay Connected with U.S. Food and Drug Administration:

SUBSCRIBER SERVICES: Manage Subscriptions  |  Unsubscribe All  |  Help

This email was sent to ooseims.archieves@blogger.com using GovDelivery Communications Cloud on behalf of: U.S. Food and Drug Administration ·  10903 New Hampshire Ave · Silver Spring, MD ·  20993-0002 ·  1-888-INFO-FDA